DUBLIN--(BUSINESS WIRE)--Sep 15, 2022--
The "Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive information about the Injectable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Injectable Drug Delivery Devices are defined as administration of a drug into patient's blood through a delivery device.
Scope
- Extensive coverage of the Injectable Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Injectable Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Injectable Drug Delivery Overview
3 Products under Development
3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery - Pipeline Products by Segment
3.3 Injectable Drug Delivery - Pipeline Products by Territory
3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery - Ongoing Clinical Trials
4 Injectable Drug Delivery - Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development
5 Injectable Drug Delivery Companies and Product Overview
6 Injectable Drug Delivery- Recent Developments
7 Appendix
Companies Mentioned
- AcelRx Pharmaceuticals Inc
- Adalvo
- AdrenaCard, Inc.
- AktiVax Inc.
- Alexion Pharmaceuticals Inc
- Allergan Ltd
- Alsensa ApS
- Amneal Pharmaceuticals Inc
- Antares Pharma Inc
- Apellis Pharmaceuticals Inc
- Aptissen SA
- Aquavit Pharmaceuticals Inc
- Artemes Technologies, Inc.
- Ascendis Pharma AS
- ASCIL Biopharm
- Ash Access Technology Inc
- ASIS Corp
- Auckland Bioengineering Institute
- AzureBio SL
- Becton Dickinson and Co
- Bespak Europe Ltd
- Biocorp Production SA
- BioCorRx Inc
- Biorchestra Co Ltd
- BioRestorative Therapies Inc
- Bioxis Pharmaceuticals
- Brigham and Women's Hospital
- Burke Pharmaceuticals LLC
- Calla Health Foundation
- Callisyn Biomedical Inc
- Cambridge Consultants Ltd
- Camurus AB
- Case Western Reserve University
- Cincinnati Children's Hospital Medical Center
- Clearside BioMedical Inc
- Coherus BioSciences Inc
- Copernicus Sp zoo
- CrossCoat Medical LLC
- Crossject SA
- DALI Medical Devices Ltd.
- DelSite, Inc. (Inactive)
- Department of Biomedical Engineering Columbia University
- Difinity Solutions
- Drexel University
- Duoject Medical Systems Inc
- Ebenroth BV
- Ecole Polytechnique Federale de Lausanne
- Elcam Medical
- EmboMedics Inc
- Embryyo Technologies Pvt Ltd
- Emergent BioSolutions Inc
- EP Global Communications Inc (Inactive)
- Eveon SAS
- EyePoint Pharmaceuticals Inc
- FHC Inc
- FluGen Inc
- Fresenius SE & Co KGaA
- GeneSYS-ID Inc
- Georgia Institute of Technology
- Ghent University
- Globe Medical Tech Inc (Inactive)
- Hillmed Inc
- Immunovant Inc
- Impulse Biomedical
- Inovio Pharmaceuticals Inc
- Inventage Lab Inc
- InVivo Therapeutics Corp
- JCR Pharmaceuticals Co Ltd
- komarik
- LG Chem Ltd
- Liposphere Ltd
- LyoGo
- Mallinckrodt Plc
- Medovate Ltd
- Mercator MedSystems Inc
- Mertiva AB
- Midas Pharma GmbH
- Milestone Scientific Inc
- Monash University
- Morimoto Pharma Co Ltd
- NanoSyrinx Ltd
- National University of Ireland Galway
- Nemera La Verpilliere
- Nipro Corp
- Nota Laboratories LLC
- Novo Nordisk AS
- Novosanis NV
- NuvOx Pharma LLC
- Ocular Therapeutix Inc
- Old Dominion University
- Osteo Pharma BV
- Oval Medical Technologies Ltd
- Owen Mumford Ltd
- Palatin Technologies Inc
- Palette Life Sciences AB
- Particle Therapeutics Ltd
- Pharmosa Biopharm Inc
- PHC Holdings Corp
- Portal Instruments Inc
- Prohibix LLC
- QuiO Technologies LLC
- Rebel Medicine Corp
- Recon Therapeutics, LLC
- Regeneron Pharmaceuticals Inc
- Renovos Biologics Ltd
- RepliCel Life Sciences Inc
- Rescitech Vision Pvt Ltd
- RetinaPharma Technologies Inc
- Sapporo Medical University School of Medicine
- Schott AG
- Singapore Eye Research Institute
- Sorrento Therapeutics Inc
- Southern Medical University
- Spinal Restoration Inc (Inactive)
- Stevanato Group SpA
- Subcuject ApS
- Sunshine Guojian Pharmaceutical Shanghai Co Ltd
- Takeda Pharmaceutical Co Ltd
- TCB medical devices
- Tempest Therapeutics Inc
- Terumo Corp
- Teva Pharmaceutical Industries Ltd
- Teva Pharmaceuticals USA Inc
- TheraKine Inc (Inactive)
- Twin Star Medical Inc
- Unilife Corporation
- University College London
- University of Calgary
- University of California San Diego
- University of California San Francisco
- University of Delaware
- University of Dundee
- University of Florida
- University of Michigan
- University of New Mexico
- University of Saskatchewan
- University of South Florida
- University of Texas at Austin
- University of Texas at San Antonio
- Vanderbilt University
- West Pharmaceutical Services Inc
- Windgap Medical Inc
- Xeris Biopharma Holdings Inc
- Ypsomed Holding AG
- ZebraSci Inc
- Zosano Pharma Corp
For more information about this report visit https://www.researchandmarkets.com/r/at87ho
View source version on businesswire.com:https://www.businesswire.com/news/home/20220915005827/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
